Literature DB >> 4028021

Increased level of amplification of the c-myc oncogene in tumors induced in nude mice by a human breast carcinoma cell line.

N Modjtahedi, C Lavialle, M F Poupon, R M Landin, R Cassingena, R Monier, O Brison.   

Abstract

Cell line SW 613-S, derived from a human breast carcinoma, contained double minute chromosomes (DMs) but lost them progressively upon in vitro cultivation. These cells were tumorigenic in nude mice. Cell lines were derived from the tumors and were found to have a high DM content. In three such cell lines, DMs were stably maintained upon in vitro cultivation, whereas in another they were progressively lost. We found that the c-myc oncogene is amplified 5- to 10-fold in SW 613-S and 20- to 90-fold in the different cell lines derived from the tumors. At least part of the additional c-myc copies were found associated with a purified DM fraction. In cell lines which lost the DMs during in vitro passages, the level of amplification was maintained. In situ hybridization experiments indicated that this loss was compensated by the acquisition of copies of the c-myc gene integrated into a chromosome. No major rearrangement of the amplified c-myc gene was detected. The amount of c-myc messenger RNAs is roughly proportional to the level of amplification. Our results indicate that growth of SW 613-S cells as tumors in nude mice selected cells with an increased level of amplification and expression of the c-myc oncogene.

Entities:  

Mesh:

Year:  1985        PMID: 4028021

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening.

Authors:  M Gunther; M Laithier; O Brison
Journal:  Mol Cell Biochem       Date:  2000-07       Impact factor: 3.396

2.  Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression.

Authors:  J Couturier; X Sastre-Garau; S Schneider-Maunoury; A Labib; G Orth
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Pleiotropic derepression of developmentally regulated cellular and viral genes by c-myc protooncogene products in undifferentiated embryonal carcinoma cells.

Authors:  R Onclercq; A Lavenu; C Cremisi
Journal:  Nucleic Acids Res       Date:  1989-01-25       Impact factor: 16.971

4.  Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.

Authors:  C Escot; C Theillet; R Lidereau; F Spyratos; M H Champeme; J Gest; R Callahan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Insufficiency of transformation by simian virus 40, polyomavirus, EJ-ras, or v-myc oncogenes for conversion of ethanolamine-responsive mammary cells to ethanolamine-nonresponsive cells.

Authors:  T Kano-Sueoka; D M King
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

6.  Selection of cells with different chromosomal localizations of the amplified c-myc gene during in vivo and in vitro growth of the breast carcinoma cell line SW 613-S.

Authors:  D Cherif; C Lavialle; N Modjtahedi; M Le Coniat; R Berger; O Brison
Journal:  Chromosoma       Date:  1989-01       Impact factor: 4.316

Review 7.  Genetic alterations in primary breast cancer.

Authors:  R Callahan
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

8.  Transcriptional deregulation of the keratin 18 gene in human colon carcinoma cells results from an altered acetylation mechanism.

Authors:  Philippe Prochasson; Cécile Delouis; Olivier Brison
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

9.  Analysis of gene amplification in human tumor cell lines.

Authors:  M Fukumoto; D H Shevrin; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

10.  An Sp1 binding site and the minimal promoter contribute to overexpression of the cytokeratin 18 gene in tumorigenic clones relative to that in nontumorigenic clones of a human carcinoma cell line.

Authors:  M Gunther; T Frebourg; M Laithier; N Fossar; M Bouziane-Ouartini; C Lavialle; O Brison
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.